Cortigent
ApprovedCortigent is developing targeted neurostimulation systems for improving the brain’s communication with specific parts of the body or to bypass injured body parts. Through their novel technology, Cortigent strives to help patients regain control of body functions they lost to disease or injury.
Founded
2021
Focus
Medical DevicesNeuroscience
About
Cortigent is developing targeted neurostimulation systems for improving the brain’s communication with specific parts of the body or to bypass injured body parts. Through their novel technology, Cortigent strives to help patients regain control of body functions they lost to disease or injury.
Funding History
2Total raised: $75M
Series B$45MCatalyst Health VenturesNov 15, 2023
Series A$30MBaird CapitalJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationSylmar, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile